- Home
- BANF vs RNA Comparison
BANF vs RNA Comparison
Compare BANF & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANF
- RNA
- Stock Information
- Founded
- BANF 1984
- RNA 2012
- Country
- BANF United States
- RNA United States
- Employees
- BANF N/A
- RNA N/A
- Industry
- BANF Major Banks
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- BANF Finance
- RNA Health Care
- Exchange
- BANF Nasdaq
- RNA Nasdaq
- Market Cap
- BANF 4.0B
- RNA 3.4B
- IPO Year
- BANF N/A
- RNA 2020
- Fundamental
- Price
- BANF $123.06
- RNA $36.24
- Analyst Decision
- BANF Hold
- RNA Strong Buy
- Analyst Count
- BANF 3
- RNA 12
- Target Price
- BANF $113.33
- RNA $67.92
- AVG Volume (30 Days)
- BANF 84.0K
- RNA 1.2M
- Earning Date
- BANF 07-17-2025
- RNA 05-08-2025
- Dividend Yield
- BANF 1.50%
- RNA N/A
- EPS Growth
- BANF 7.83
- RNA N/A
- EPS
- BANF 6.60
- RNA N/A
- Revenue
- BANF $638,713,000.00
- RNA $8,927,000.00
- Revenue This Year
- BANF $8.95
- RNA N/A
- Revenue Next Year
- BANF $3.66
- RNA $148.12
- P/E Ratio
- BANF $18.65
- RNA N/A
- Revenue Growth
- BANF 7.39
- RNA N/A
- 52 Week Low
- BANF $81.56
- RNA $21.51
- 52 Week High
- BANF $132.29
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- BANF 51.59
- RNA 69.07
- Support Level
- BANF $120.20
- RNA $33.41
- Resistance Level
- BANF $124.49
- RNA $32.09
- Average True Range (ATR)
- BANF 2.65
- RNA 1.68
- MACD
- BANF -0.94
- RNA 0.58
- Stochastic Oscillator
- BANF 28.95
- RNA 90.36
About BANF BancFirst Corporation
BancFirst Corp is engaged in providing banking services. The company's business unit includes BancFirst metropolitan banks, BancFirst community banks, Pegasus Bank, Worthington, other financial services and executive, operations and support. BancFirst metropolitan banks, BancFirst community banks, Pegasus and Worthington offer traditional banking products such as commercial and retail lending and a full line of deposit accounts. Other financial services are specialty product business units including guaranteed small business lending, residential mortgage lending, trust services, securities brokerage, electronic banking, and insurance.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.